CV Events Death Lower After Statin Rechallenge
Getting patients to stay on statins after an adverse reaction is getting harder though in the face of a growing "cult" of online antistatin sentiment one expert says. Medscape Medical...
View ArticleFDA Grants Priority Review For Amgen's Supplemental Biologics License...
THOUSAND OAKS Calif. July 27 2017 PRNewswire Amgen NASDAQAMGN today announced that the U.S. Food and Drug Administration FDA has granted priority review for Amgen's supplemental Biologics License...
View ArticleCath Lab Recap Statin Use Through Thick & Thin; Visor That IDs Stroke Type
MedPage Today Interventional cardiology news to note
View ArticleJul 28 Cardiology News
Obstructive sleep apnea changes in diet AF ablation statin rechallenge and prediabetes are covered in this week's podcast. theheart.org on Medscape
View ArticleIntercept Pharma Release CONTROL Trial Shows Statin Therapy Reversed LDL...
Life Sciences Jobs ...
View ArticleNo evidence higher doses of cholesterollowering drug increase risk of acute...
New Zealanders taking a higher dose of simvastatin one of the cholesterollowering statin drugs used to prevent heart attacks and strokes do not appear to have a higher risk of acute kidney damage than...
View ArticleDaiichi Sankyo Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryDaiichi Sankyo Inc Daiichi Sankyo a subsidiary of Daiichi Sankyo Company Ltd is a healthcare products provider that discovers and develops medicines for cardiovascular and metabolic disorders....
View ArticleNearly all men over 60 and women over 75 eligible for statins analysis...
The GuardianNearly all men over 60 and women over 75 eligible for statins analysis suggestsThe GuardianThe analysis studied the Niceendorsed algorithm for calculating cardiovascular disease risk and...
View ArticleNICE guidelines could put 12 million UK adults on statins
Almost all men over 60 and all women over 75 in England qualify for statin prescriptions under guidelines adopted by the National Institute for Health and Care Excellence NICE in 2014 a new...
View ArticleMore older adults 'may benefit from taking statins' study reports
"Nearly all men over 60 and women over 75 eligible for statins analysis suggests" The Guardian reports. This is the finding of a study that aimed to see how many people in England...
View ArticleAtherosclerotic Plaque Vulnerability in the Statin Era
This paper examines possible pathophysiological mechanisms of plaque vulnerability in statintreated patients with established CVD with a view towards identifying risk factors for rupture. European...
View ArticleQuitting statins after stroke may raise risk of another stroke
Stroke patients who stopped taking statin drugs three to six months after a first ischemic stroke the type caused by narrowed arteries had a higher risk of a having another stroke within a year...
View ArticleStopping Statins After Stroke May Raise Risk of Another
WEDNESDAY Aug. 2 2017 Stroke survivors who stop taking cholesterollowering statins are at increased risk for another stroke a new study finds.Researchers studied more than 45000 ischemic stroke...
View ArticleForget PCSK9 Drugs Almost All Could Reach Target LDL With Oral Agents CMECE
Debate is done MedPage Today focus on intense statin and ezetimibe use groups argue
View ArticleInfection CV Risk; Statin Key After Stroke; Sodium Strains the Heart
MedPage Today Cardiovascular Daily wraps up the top cardiology news of the week
View ArticleInfection CV Risk; Statin Key After Stroke
MedPage Today Cardiovascular Daily wraps up the top cardiology news of the week
View ArticleWhy Are So Many People Stopping Their Statins
Nearly half of people with high levels of cholesterol stop taking their prescription statin medications
View ArticleEsperion hits a homer with new cholesterol data
Stock surged on news that patients taking a statin and a drug combination including its bempedoic acid had a 64 reduction in bad cholesterol levels.
View ArticleTriplet Therapy & Q22017 Results ESPR Spike
On Tuesday morning August 8 2017 Esperion Therapeutics ESPR releasedits Q22017 results and held a conference call with presentation slides. The clear focus was on the results from the Triplet Therapy...
View Article